AVITA Medical (RCEL) Cash & Current Investments (2018 - 2025)

AVITA Medical's Cash & Current Investments history runs 8 years deep, the most recent figure standing at $16.3 million for Q4 2025.

• Quarterly Cash & Current Investments fell 54.46% year-over-year to $16.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $16.3 million (down 54.46% YoY) and the FY2025 annual result came in at $16.3 million, down 54.46% from the prior year.
• Cash & Current Investments was $16.3 million for Q4 2025 at AVITA Medical, down from $23.3 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $115.1 million in Q1 2021 and bottomed at $14.1 million in Q2 2025.
• A 5-year average of $63.2 million and a median of $69.2 million in 2023 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2021 — Cash & Current Investments jumped 49.98% — and 2025, when it slumped 70.31%.
• AVITA Medical's Cash & Current Investments stood at $85.4 million in 2021, then fell by 11.81% to $75.3 million in 2022, then gained by 4.07% to $78.3 million in 2023, then tumbled by 54.19% to $35.9 million in 2024, then sank by 54.46% to $16.3 million in 2025.
• Business Quant data shows RCEL's Cash & Current Investments at $16.3 million in Q4 2025, $23.3 million in Q3 2025, and $14.1 million in Q2 2025.